NewEdge Advisors’s P3 Health Partners PIII Stock Holding History

NewEdge Advisors’s Portfolio PIII Stock Details PIII Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-2	Closed	-$184	–	3946
2022 Q4	$184	Buy	+2	New	+$433	﹤0.01%	3309

Other funds holding PIII

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

EMFO LLC Weston, Florida $112M AUM 18.79% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

NewEdge Advisors's PIII Position: Q1 2023 in Review

NewEdge Advisors sold out of P3 Health Partners (PIII) in Q1 2023, closing a stake of 2 shares — an estimated $184 sold.

NewEdge Advisors first reported a position in PIII in Q4 2022 and held it in 1 quarter. The position peaked at $184 in Q4 2022. 46 funds tracked by Wall St. Rank hold PIII as of Q1 2023.

NewEdge Advisors reported no remaining P3 Health Partners position as of Q1 2023 after selling out during the quarter.
NewEdge Advisors sold 2 P3 Health Partners shares in Q1 2023, an estimated $184.
NewEdge Advisors first reported a position in P3 Health Partners in Q4 2022 and held it in 1 quarter.
NewEdge Advisors's P3 Health Partners position peaked at $184 in Q4 2022.
46 funds tracked by Wall St. Rank held P3 Health Partners as of Q1 2023.

Based on NewEdge Advisors's 13F filing for Q1 2023, filed 12 May 2023.